首页> 外文期刊>In vivo. >Clinical and radiological outcome after endovascular abdominal aortic aneurysm repair: comparison of different grafts. preliminary single-center experience.
【24h】

Clinical and radiological outcome after endovascular abdominal aortic aneurysm repair: comparison of different grafts. preliminary single-center experience.

机译:腹血管腹主动脉瘤修复后的临床和放射性结果:不同移植物的比较。 初步单中心体验。

获取原文
获取原文并翻译 | 示例
           

摘要

Endovascular repair (EVAR) represents a useful and validated alternative to conventional surgery in selected patients with abdominal aortic aneurysm (AAA) because it is associated with a significantly lower long-term AAA-related mortality. Data regarding a series of 91 patients (88 men, 3 women, median age 71 years, range 65-82 years) is reported. The patients were divided into three groups, according to the type of implanted stent (Endurant, Excluder and Talent). High American Society of Anesthesiologists Physical Status Classification System (ASA) was important in increasing the likelihood of an early complication (p=0.0007), while it did not have any effect on later adverse events, which were more closely related to the size of the aneurysm (p=0.006). As expected, the aneurysm diameter influenced the endoleak incidence (p=0.011), aneurysmal sac expansion (p=0.029), re-intervention risk (p=0.031) and the success of treatment (p=0.006). A significantly lower tendency for the development of endoleak (p=0.035) and other late complications (p=0.048) was observed in patients with Endurant device. This group seems to be more likely destined to achieve therapeutic success, but the difference was not significant. A borderline significance (p=0.071) with regard to early complications was also recorded. However, the use of this type of device did not affect survival, which was exclusively related to ASA (p=0.040). No other statistically significant differences were found between groups. Since open surgery for elective suprarenal AAA repair is still associated with considerable mortality, EVAR may offer several advantages over open repair surgery, including a less invasive operative procedure, and shortened intensive care unit and hospital stay. The technological improvements of the prosthesis for EVAR will likely reduce complications related to this technique in the near future.
机译:血管内修复(EVAR)代表了腹主动脉瘤(AAA)所选患者中常规手术的有用和验证的替代物,因为它与显着降低的长期AAA相关的死亡率有关。有关一系列91名患者的数据(88名男子,3名女性,71岁,65-82岁的中位数)。根据植入支架(耐营,排除和人才)的类型,患者分为三组。高美国麻醉学士学位物理状态分类系统(ASA)对于提高早期并发症的可能性(p = 0.0007)很重要,而它对后来的不良事件没有任何影响,这与较大的关系更密切相关动脉瘤(P = 0.006)。正如预期的那样,动脉瘤直径影响了止吐胚胎入射(P = 0.011),动脉瘤囊膨胀(P = 0.029),再干预风险(P = 0.031)和治疗的成功(P = 0.006)。在较耐核性装置患者中观察到胚乳的发展(P = 0.035)和其他晚期并发症(P = 0.048)的显着降低的趋势。该集团似乎更有可能注定要实现治疗成功,但差异并不重要。还记录了早期并发症的边界意义(P = 0.071)。然而,这种类型的装置的使用并不影响生存率,其专门与ASA相关(P = 0.040)。在组之间没有发现其他统计学上的显着差异。由于选择性寄生术AAA修复的开放手术仍然具有相当大的死亡率,EVAR可能提供开放式修复手术的若干优势,包括较少的侵入性手术程序,并缩短重症监护单元和住院。 EVAR假体的技术改善可能会在不久的将来减少与该技术有关的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号